Toward Second-Generation Cardiomyogenic and Anti-cardiofibrotic 1,4-Dihydropyridine-Class TGFβ Inhibitors. - Längle D; Werner TR; Wesseler F; Reckzeh E; Schaumann N; Drowley L; Polla M; Plowright AT; Hirt MN; Eschenhagen T; Schade D (ChemMedChem, 2019)